Prostate cancer patients on androgen deprivation therapy (ADT) experience adverse effects such as lean mass loss, known as sarcopenia, fat gain, and changes in cardiometabolic factors that increase risk of metabolic syndrome (MetS). | Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer A pilot randomized controlled trial